Hao-hang Zhang

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
AIM Premixed insulin regimens are commonly used for the treatment of patients with type-2 diabetes mellitus (T2DM). However, limited data are available regarding next-step therapy options in cases where premixed insulin fails to provide adequate glycemic control. This 20-week observational study of everyday clinical practice evaluated the efficacy, safety(More)
  • 1